KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 133 filers reported holding KARUNA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 3.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,445,350 | +156.2% | 115,000 | +228.6% | 2.59% | +151.4% |
| Q2 2023 | $7,589,750 | -58.2% | 35,000 | -65.0% | 1.03% | -60.3% |
| Q1 2023 | $18,164,000 | -38.4% | 100,000 | -33.3% | 2.60% | -24.7% |
| Q4 2022 | $29,475,000 | -12.6% | 150,000 | 0.0% | 3.45% | -16.8% |
| Q3 2022 | $33,740,000 | +77.8% | 150,000 | 0.0% | 4.15% | +19.1% |
| Q2 2022 | $18,977,000 | -56.0% | 150,000 | -55.9% | 3.48% | -37.7% |
| Q1 2022 | $43,109,000 | +9.7% | 340,000 | +13.3% | 5.59% | +37.9% |
| Q4 2021 | $39,300,000 | -30.2% | 300,000 | -34.8% | 4.05% | -0.1% |
| Q3 2021 | $56,272,000 | +51.9% | 460,000 | +41.5% | 4.06% | +30.3% |
| Q2 2021 | $37,047,000 | +54.1% | 325,000 | +62.5% | 3.11% | +32.7% |
| Q1 2021 | $24,046,000 | +97.2% | 200,000 | +66.7% | 2.35% | +124.6% |
| Q4 2020 | $12,191,000 | +143.1% | 120,000 | +72.3% | 1.04% | -45.2% |
| Q1 2020 | $5,015,000 | +67.9% | 69,658 | +75.7% | 1.91% | +159.2% |
| Q4 2019 | $2,987,000 | – | 39,647 | – | 0.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
| Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
| Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
| First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
| Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
| DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
| Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
| GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
| MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
| Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |